A Phase 2b Study of Icosabutate in Fatty Liver Disease

Clinical trial NCT04052516 · COMPLETED

Trial details

NCT number: NCT04052516
Sponsor: NorthSea Therapeutics B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Alcoholic Steatohepatitis (NASH)

Start date: 2019-07-17
Primary completion: 2022-02-20
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.